Mithu
★    

India,
2023-05-04 06:59
(442 d 15:19 ago)

Posting: # 23541
Views: 2,038
 

 505 b(2) application & requirement of bio­equi­va­lence [Regulatives / Guidelines]

Hello All,


My question is, "is it mandatory to have 505b(2) application bio-equivalent to current reference listed drug?"

regards,

Mithu
dshah
★★  

India/United Kingdom,
2023-05-05 15:38
(441 d 06:39 ago)

@ Mithu
Posting: # 23545
Views: 1,668
 

 505 b(2) application & requirement of bioequivalence

Hello Mithu!

As we rely on existing PKPD relationship, toxicity data and other pharmacology data of reference drug, the BE is required.

Regards,
Divyen
Mithu
★    

India,
2023-05-11 09:58
(435 d 12:20 ago)

@ dshah
Posting: # 23548
Views: 1,586
 

 505 b(2) application & requirement of bioequivalence

Hi Divyen,

Thank you for your reply.

regards,

Mithu
Achievwin
★    

US,
2023-05-05 18:08
(441 d 04:10 ago)

@ Mithu
Posting: # 23546
Views: 1,704
 

 505 b(2) application & requirement of bio­equi­va­lence

Hello Mithu:

505 (b)(2) is all about the submission and marketing strategy. Most of the 505(b)(2) applications take BE route as drug Chemistry, safety and efficacy along with biopharmaceutics is already known and BE is used as a knowledge (claim) gap bridging approach. There are other means you can get 505(b)(2. Please review different guidance (FDA, EMA etc.) or white papers on 505(b)(2).

Hope this helps
Mithu
★    

India,
2023-05-11 09:58
(435 d 12:19 ago)

@ Achievwin
Posting: # 23549
Views: 1,597
 

 505 b(2) application & requirement of bio­equi­va­lence

Hello Achievwin,

Thank you for your reply.

regards,

Mithu
UA Flag
Activity
 Admin contact
23,112 posts in 4,858 threads, 1,644 registered users;
74 visitors (0 registered, 74 guests [including 13 identified bots]).
Forum time: 22:18 CEST (Europe/Vienna)

Skill is a function of chance.
It’s an intuitive best-use of chance situations.    Philip K. Dick

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5